We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Seth Berkman Seth Berkman is a writer covering fitness. He's showered ...
And how could we not be? We live in a go, go, go society where everything and everyone is vying for our attention — our families, friends, work, the 24-hour news cycle and social media, just to name a ...
Other common side effects of benzodiazepines and Z-drugs include: continuous positive airway pressure (CPAP) devices to treat obstructive sleep apnea specific antidepressants to treat insomnia ...
INDIANAPOLIS (WISH) – The FDA has now approved Lilly’s Zepbound (glp-1 agonist) for sleep apnea. It’s the first medication approved for this condition. Sleep apnea affects 25 million ...
The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...
27 to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, making it the first medication for certain patients with the condition. The agency green-lit the ...